Immune cell profiling is becoming an increasingly indispensable part of the drug development process; insights gained from immune profiling can be used to optimize therapeutic design and treatment strategies.

Identifying the right approach to immune profiling at each stage of clinical development may be critical for advancing promising drug candidates and monitoring therapeutic efficacy. This white paper will help you:

• Understand the choices and technologies available for immune monitoring
• Learn about epigenetic immune monitoring and how it differs from and complements flow cytometry
• Determine the benefits and challenges of differing immune monitoring techniques, and at which stage of development these benefits may be best leveraged